Wednesday 16 October 2019 ,
Wednesday 16 October 2019 ,
Latest News
  • PM urges all to be responsible on road to avert accident
  • PM to attend 18th NAM Summit in Baku Oct 25-26
  • Food safety still a far cry: BSTI finds 30 more items substandard
  • ‘Robber’ killed in ‘gunfight’ with police in Feni
  • ‘16pc people suffer from kidney diseases for adulterated food intake’
  • New list of 50,000 Rohingyas handed over to Myanmar
19 August, 2019 00:00 00 AM

Deadly new fungal superbug is worrying doctors — here's what you need to know

Yahoo Style
Deadly new fungal superbug is worrying doctors — here's what you need to know

ABBY HAGLAGE

Months after health officials in New York, New Jersey and Illinois raised concerns about a new deadly fungal superbug, a study has suggested climate change may be playing a role in its troubling rise.

“Candida auris fungus” (C. auris) is a multi-drug–resistant fungal infection that spreads in hospitals and is extremely deadly — killing as many as one in three who get it, according to the Centers for Disease Control and Prevention (CDC).

While there are likely many reasons that the infection has now spread to 30 countries, authors of the study — published this week in the journal mBio — are blaming climate change. The researchers say global warming has played a “pivotal role” in the infection’s rise, citing the fungus’s ability to “grow at higher temperatures.”

"What this study suggests is this is the beginning of fungi adapting to higher temperatures, and we are going to have more and more problems as the century goes on," Arturo Casadevall, MD, PhD, and Molecular Microbiology and Immunology chair at Johns Hopkins Bloomberg School of Public Health said. "Global warming will lead to selection of fungal lineages that are more thermally tolerant.”

As scientists continue to unpack what’s fueling the rise of this infection, here’s what those who are vulnerable to it need to know.

The infection started in Japan.

C. auris was initially discovered in a Japanese man with an ear infection in 2009. It first appeared in the U.S. in 2013, specifically in a series of patients at a New Jersey hospital. Since then, the CDC has tracked over 700 cases nationwide.

Symptoms are difficult to pinpoint.

According to a CDC fact sheet, the fungus can cause “blood stream infections” and is often spread in hospitals and between nursing home patients. Symptoms are contingent on which part of the body has become infected with the illness, but can include chills and fever. A laboratory test is needed to confirm that it is C. auris that’s present, at which point treatment (often with multiple anti-fungal medications) begins.

Hospital patients and the elderly are most at risk.

Like other drug-resistant infections such as C.difficle, C. auris poses the most risk to individuals whose immune systems are already compromised — such as those in the hospital, elderly people and those who use breathing tubes. The CDC notes that “healthy people usually don’t get C. auris infections.”

New York has the highest cases, likely due to travel.

In an email to Yahoo Lifestyle, Michael Phillips, MD, chief epidemiologists and associate professor of infectious diseases at NYU Langone Health, says that C. auris is “following the same pattern” as another drug-resistant bacteria, one which started in New York and then spread nationwide. “This is likely due to travel to and from the NYC area,” he says.

It may not technically be a “superbug.”

The Mayo Clinic defines superbugs as “strains of bacteria that are resistant to the majority of antibiotics commonly used today,” but although many have been referring to C. auris as one, Phillips doesn’t necessarily agree. “In spite of the hype, I would not call C auris a superbug,” says Phillips. His reasoning, in part, is that not all C. auris infections are resistant to drugs.

There is no need to panic.

In an editorial for the Harvard Medical School in May, Robert H. Shmerling, MD, noted that while C. auris is a dangerous infection, panic among the general population is not warranted. “Fortunately, Candida auris has not spread to wide swaths of the population, and healthy people rarely develop the infection,” he writes. “When it comes to infectious disease, it’s never time to panic. Instead, you can take constructive steps to deal with concerns about a wide array of infections, even the deadliest ones.”

A great way to start, he says, is regularly washing your hands, receiving all your vaccinations and avoiding people who are contagious.

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

A joint is formed where two or more bones of skeleton meet one another. The long bones join by their ends and flat bones by their sides. They are mainly…
The basics of arthritis

The basics of arthritis

Arthritis is a broad term that covers a group of over 100 diseases. It has everything to do with your joints -- the places where your bones connect --…
Arthritis treatment 
options

Arthritis treatment options

The treatment options covered in this article relate to osteoarthritis, although many of them may be effective rheumatoid arthritis treatments. Please…
Arthrocentesis and joint injections

Arthrocentesis and joint injections

Arthrocentesis means aspiration of fluid from a joint space which is usually done by placing a needle into a joint space and withdrawing fluid in to a…
Rheumatoid and musculoskeletal diseases (RMDs)

Rheumatoid and musculoskeletal diseases (RMDs)

RMDs are commonly classified into inflammatory and non-inflammatory types: Common non-inflammatory RMDs consist of degenerative spine diseases, osteoarthritis,…
An overview of arthritis mutilans

An overview of arthritis mutilans

LANA BARHUM Arthritis mutilans is a severe form of chronic rheumatoid arthritis or psoriatic arthritis. It is characterized by severe inflammation that…
Paralysed man moves in mind-reading exoskeleton

Paralysed man moves in mind-reading exoskeleton

JAMES GALLAGHER  FA man has been able to move all four of his paralysed limbs with a mind-controlled exoskeleton suit, French researchers report.…
Pain Management of older persons: physiotherapy is the hope

Pain Management of older persons: physiotherapy is the hope

Every year on 1st October, WHO has been playing a significant role in celebrations, and actively promoting public awareness of the “International…
Pain Management of older persons: physiotherapy is the hope

Pain Management of older persons: physiotherapy is the hope

Every year on 1st October, WHO has been playing a significant role in celebrations, and actively promoting public awareness of the “International…
Chinese study reveals underuse of lifesaving drugs after heart attacks

Chinese study reveals underuse of lifesaving drugs after heart attacks

Many heart attack patients in China fail to receive beta-blockers which could prevent another event and save their life. The research is presented at…
Humans may possess ability to regrow cartilage

Humans may possess ability to regrow cartilage

Humans may lack the salamander skill of regrowing a limb, but a new study suggests they do have some capacity to restore cartilage in their joints. The…
Prescribed Zantac heartburn medicine recall in UK

Prescribed Zantac heartburn medicine recall in UK

UK doctors are being told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a "precautionary measure".…
FDA approves Ibsrela (tenapanor) for the treatment of Irritable Bowel Syndrome with constipation

FDA approves Ibsrela (tenapanor) for the treatment of Irritable Bowel Syndrome with constipation

Ardelyx, Inc. recently announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the treatment…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting